GENERIC VS BRAND NAME LEVOTHYROXINE

通用名与品牌名左旋甲状腺素

• 批准号: 7607295
• 负责人: Rosalind Brown
• 金额: $ 3.18万
• 依托单位: BOSTON CHILDREN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7607295
• 关键词: Computer Retrieval of Information on Scientific Projects Database; Funding; Generic Drugs; Grant; Institution; Names; Preparation; Research; Research Personnel; Resources; Source; Thyrotropin; Thyroxine; United States Food and Drug Administration; United States National Institutes of Health

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The specific aim of this study is to determine whether there is a significant difference in thyroid stimulating hormone levels between two different preparations of levothyroxine that are declared therapeutically equivalent by the FDA.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 这项研究的具体目的是确定甲状腺刺激激素水平是否存在显着差异，而左甲状腺素的两种不同制剂则被FDA宣布为治疗等效。